Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 3
2005 6
2006 7
2007 9
2008 7
2009 12
2010 13
2011 9
2012 7
2013 8
2014 14
2015 7
2016 17
2017 25
2018 18
2019 21
2020 28
2021 55
2022 75
2023 60
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

375 results

Results by year

Filters applied: . Clear all
Page 1
Immunosenescence: molecular mechanisms and diseases.
Liu Z, Liang Q, Ren Y, Guo C, Ge X, Wang L, Cheng Q, Luo P, Zhang Y, Han X. Liu Z, et al. Among authors: cheng q. Signal Transduct Target Ther. 2023 May 13;8(1):200. doi: 10.1038/s41392-023-01451-2. Signal Transduct Target Ther. 2023. PMID: 37179335 Free PMC article. Review.
Glioma targeted therapy: insight into future of molecular approaches.
Yang K, Wu Z, Zhang H, Zhang N, Wu W, Wang Z, Dai Z, Zhang X, Zhang L, Peng Y, Ye W, Zeng W, Liu Z, Cheng Q. Yang K, et al. Among authors: cheng q. Mol Cancer. 2022 Feb 8;21(1):39. doi: 10.1186/s12943-022-01513-z. Mol Cancer. 2022. PMID: 35135556 Free PMC article. Review.
Tumor buster - where will the CAR-T cell therapy 'missile' go?
Qu C, Zhang H, Cao H, Tang L, Mo H, Liu F, Zhang L, Yi Z, Long L, Yan L, Wang Z, Zhang N, Luo P, Zhang J, Liu Z, Ye W, Liu Z, Cheng Q. Qu C, et al. Among authors: cheng q. Mol Cancer. 2022 Oct 19;21(1):201. doi: 10.1186/s12943-022-01669-8. Mol Cancer. 2022. PMID: 36261831 Free PMC article. Review.
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer.
Zhang H, Dai Z, Wu W, Wang Z, Zhang N, Zhang L, Zeng WJ, Liu Z, Cheng Q. Zhang H, et al. Among authors: cheng q. J Exp Clin Cancer Res. 2021 Jun 4;40(1):184. doi: 10.1186/s13046-021-01987-7. J Exp Clin Cancer Res. 2021. PMID: 34088360 Free PMC article. Review.
375 results